Get the Stockscreener App
2.36
4.45%
-0.11
After Hours:
2.29
-0.07
-2.97%
Casi Pharmaceuticals Inc Stock (CASI) Forecast
The Casi Pharmaceuticals Inc (CASI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.856, representing a +63.39% increase from the current price of $2.36. The highest analyst price target is $3.7591, and the lowest is $3.9529.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CASI Price Target
Average 8.9042
(+277.30% Upside)
Is Casi Pharmaceuticals Inc (CASI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 64.32 | Neutral |
| STOCH(9,6) | 48.07 | Neutral |
| STOCHRSI(14) | 76.94 | Neutral |
| MACD(12,26) | 0.197 | Buy |
| ADX(14) | 38.53 | Buy |
| William %R | -46.62 | Neutral |
| CCI(14) | 60.09 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.9452
Buy
|
2.0146
Buy
|
| MA20 |
1.7586
Buy
|
1.8328
Buy
|
| MA50 |
1.5382
Buy
|
1.6985
Buy
|
| MA100 |
1.7443
Buy
|
1.8706
Buy
|
| MA200 |
2.4715
Sell
|
2.4928
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, CASI could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CASI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 64.32 indicates that CASI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.07 indicates that CASI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 76.94 indicates that CASI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.53 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 60.09 indicates that CASI is still overbought but not to an extreme extent.
Long-term CASI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Casi Pharmaceuticals Inc financial reports and earnings history, Casi Pharmaceuticals Inc (CASI) stock could reach $29.14 by 2030, $22.05 by 2040 and $66.59 by 2050. See the projected annual prices until 2050 of the Casi Pharmaceuticals Inc stock below:
- Casi Pharmaceuticals Inc (CASI) is expected to reach an average price of $4.072 in 2035, with a high prediction of $6.5054 and a low estimate of $5.422. This indicates an $72.54% rise from the last recorded price of $2.36.
- Casi Pharmaceuticals Inc (CASI) stock is projected to chart a bullish course in 2040, with an average price target of $22.01, representing an $832.61% surge from its current level. The forecast ranges from a conservative $22.06 to a sky-high $22.05.
- Our analysts predict Casi Pharmaceuticals Inc (CASI) to jump 1,741% by 2045, soaring from $43.19 to an average price of $43.46, potentially reaching $43.43. While $43.19 is the low estimate, the potential upside is significant.
- Casi Pharmaceuticals Inc (CASI) stock is expected to climb by 2050, reaching an average of $65.57, a $2,678% jump from its current level. However, a wide range of estimates exists, with high and low targets of $66.59 and $66.15, respectively, highlighting the market's uncertainty.
Casi Pharmaceuticals Inc Stock (CASI) Year by Year Forecast
Casi Pharmaceuticals Inc Stock (CASI) Price Forecast for 2025
Casi Pharmaceuticals Inc Stock (CASI) is expected to reach an average price of $3.8645 in 2025, with a high prediction of $7.4801 and a low estimate of $0.2488. This indicates an +63.75% rise from the last recorded price of $2.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $5.1591 | $3.9529 | $3.7591 | +118.61% |
| October, 2025 | $7.3695 | $5.1112 | $6.0695 | +212.27% |
| November, 2025 | $7.7778 | $7.5736 | $7.0778 | +229.57% |
| December, 2025 | $0.9119 | $5.2881 | $7.1799 | -61.36% |
Casi Pharmaceuticals Inc Stock (CASI) Price Forecast for 2026
The predicted value for Casi Pharmaceuticals Inc (CASI) in 2026 is set at an average of $8.9042. Estimates vary from a peak of $17.78 to a trough of $0.0255, indicating an +277.30% surge from the present price of $2.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0036 | $0.8154 | $7.5036 | -15.10% |
| February, 2026 | $5.6953 | $0.4974 | $6.1953 | +141.33% |
| March, 2026 | $12.49 | $5.7932 | $13.89 | +429.11% |
| April, 2026 | $6.9767 | $6.2787 | $17.78 | +195.62% |
| May, 2026 | $3.6684 | $0.0255 | $7.5746 | +55.44% |
| June, 2026 | $0.1601 | $0.5399 | $3.8663 | -93.22% |
| July, 2026 | $5.1503 | $2.842 | $3.6003 | +118.23% |
| August, 2026 | $2.2586 | $2.9586 | $3.2523 | -4.30% |
| September, 2026 | $4.7689 | $3.8606 | $3.6689 | +102.07% |
| October, 2026 | $6.5772 | $5.771 | $5.8772 | +178.70% |
| November, 2026 | $1.9855 | $3.1855 | $4.4813 | -15.87% |
| December, 2026 | $5.5958 | $2.2876 | $4.7958 | +137.11% |
Casi Pharmaceuticals Inc Stock (CASI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Casi Pharmaceuticals Inc (CASI) is $7.8214, with a high forecast of $10.04 and a low forecast of $5.5979. This indicates an +231.42% increase from the last price of $2.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.2041 | $5.5979 | $5.5041 | +162.89% |
| February, 2027 | $7.3864 | $6.4083 | $5.9724 | +212.98% |
| March, 2027 | $7.5438 | $7.8946 | $7.5058 | +219.65% |
| April, 2027 | $8.6041 | $8.0248 | $7.231 | +264.58% |
| May, 2027 | $8.3983 | $9.0323 | $8.8352 | +255.86% |
| June, 2027 | $6.4997 | $6.5497 | $7.5414 | +175.41% |
| July, 2027 | $6.461 | $6.461 | $5.8509 | +173.77% |
| August, 2027 | $8.3673 | $7.4061 | $7.6663 | +254.55% |
| September, 2027 | $9.9766 | $9.9303 | $9.7225 | +322.74% |
| October, 2027 | $10.30 | $10.23 | $10.04 | +336.65% |
| November, 2027 | $9.9532 | $10.11 | $9.9392 | +321.75% |
| December, 2027 | $8.9236 | $9.9191 | $9.8653 | +278.12% |
Casi Pharmaceuticals Inc Stock (CASI) Price Forecast for 2028
In 2028, Casi Pharmaceuticals Inc (CASI) is projected to reach an average price of $7.0119, with a high projection of $9.1884 and a low estimate of $4.8354. This indicates an +197.11% rise from the last price of $2.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.2418 | $8.4018 | $8.1556 | +249.23% |
| February, 2028 | $9.0201 | $7.746 | $8.5701 | +282.21% |
| March, 2028 | $9.1605 | $8.9222 | $9.1884 | +288.16% |
| April, 2028 | $8.7688 | $8.8688 | $8.9226 | +271.56% |
| May, 2028 | $8.7291 | $8.5948 | $8.6008 | +269.88% |
| June, 2028 | $7.8674 | $7.9574 | $8.3612 | +233.36% |
| July, 2028 | $7.5357 | $7.5657 | $7.6795 | +219.31% |
| August, 2028 | $7.1261 | $7.2161 | $7.3978 | +201.95% |
| September, 2028 | $4.8843 | $6.3393 | $6.9831 | +106.96% |
| October, 2028 | $5.6226 | $5.4128 | $5.2626 | +138.25% |
| November, 2028 | $4.853 | $4.913 | $5.3647 | +105.63% |
| December, 2028 | $4.8113 | $4.8354 | $5.0971 | +103.87% |
Casi Pharmaceuticals Inc Stock (CASI) Price Forecast for 2029
The 2029 price forecast for Casi Pharmaceuticals Inc Stock (CASI) is $13.77 on average, with a high prediction of $27.52 and a low estimate of $0.0156. This represents an +483.38% increase from the previous price of $2.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.4116 | $4.4634 | $4.5083 | +86.93% |
| February, 2029 | $4.0199 | $4.1899 | $4.1158 | +70.34% |
| March, 2029 | $3.9282 | $3.9582 | $3.8907 | +66.45% |
| April, 2029 | $3.0265 | $3.1465 | $3.7503 | +28.24% |
| May, 2029 | $0.7568 | $1.3155 | $1.9086 | -67.93% |
| June, 2029 | $0.8249 | $0.033 | $0.979 | -65.05% |
| July, 2029 | $2.7866 | $0.7378 | $3.9107 | +18.08% |
| August, 2029 | $2.9762 | $0.5504 | $4.2083 | +26.11% |
| September, 2029 | $2.0579 | $1.7779 | $3.4042 | -12.80% |
| October, 2029 | $0.0576 | $0.0397 | $3.6617 | -97.56% |
| November, 2029 | $0.3607 | $0.0156 | $0.8834 | -84.72% |
| December, 2029 | $28.62 | $0.0169 | $27.52 | +1,113% |
Casi Pharmaceuticals Inc Stock (CASI) Price Forecast for 2030
Casi Pharmaceuticals Inc Stock (CASI) is expected to reach an average price of $28.03 in 2030, with a high forecast of $33.11 and a low forecast of $22.95. This signifies an +1,088% surge from the last price of $2.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $29.64 | $30.33 | $29.14 | +1,156% |
| February, 2030 | $28.36 | $30.26 | $28.55 | +1,102% |
| March, 2030 | $28.52 | $28.37 | $27.20 | +1,109% |
| April, 2030 | $25.89 | $28.59 | $28.18 | +997.05% |
| May, 2030 | $24.21 | $24.61 | $23.81 | +925.90% |
| June, 2030 | $23.03 | $24.93 | $25.22 | +875.75% |
| July, 2030 | $22.45 | $23.85 | $23.04 | +851.20% |
| August, 2030 | $23.26 | $22.95 | $22.96 | +885.80% |
| September, 2030 | $23.18 | $23.62 | $23.17 | +882.27% |
| October, 2030 | $31.05 | $23.19 | $29.20 | +1,216% |
| November, 2030 | $37.12 | $32.81 | $33.11 | +1,473% |
| December, 2030 | $33.50 | $33.23 | $31.34 | +1,320% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):